Literature DB >> 3123069

Class II molecules on rat alveolar type II epithelial cells.

R J Harbeck1, N W Gegen, D Struhar, R Mason.   

Abstract

Class II (Ia) molecules of the major histocompatibility complex are important in the presentation of antigen to T cells and in the regulation of the immune response. Recent studies have suggested that many epithelial cell types can express class II molecules. We examined rat alveolar type II epithelial cells, a cell which can synthesize and secrete pulmonary surface-active material, for the expression of class II antigens. Using an indirect immunofluorescent technique with a mouse anti-rat class II monoclonal antibody (OX-4), the majority of type II cells isolated from pathogen-free Sprague-Dawley rats expressed Ia antigens as determined by fluorescent microscopy and cell sorter analysis. In culture, the Ia expression was lost from type II cells. The addition of recombinant interferon-gamma to cultures of type II cells induced the expression of class II antigens. These findings suggest that class II antigen expression on type II cells may have relevance to immune responses occurring in the lung.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3123069     DOI: 10.1016/0008-8749(88)90058-5

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

1.  Increased expression of class II antigens of the major histocompatibility complex on alveolar macrophages and alveolar type II cells and interleukin-1 (IL-1) secretion from alveolar macrophages in an animal model of silicosis.

Authors:  D J Struhar; R J Harbeck; N Gegen; H Kawada; R J Mason
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

2.  Replication of parainfluenza (Sendai) virus in isolated rat pulmonary type II alveolar epithelial cells.

Authors:  W L Castleman; P J Northrop; P K McAllister
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

3.  Treatment with keratinocyte growth factor does not improve lung allograft survival in the rat.

Authors:  Markus Hirschburger; Martin Obert; Horst Traupe; Tim Kuchenbuch; Winfried Padberg; Heinz Fehrenbach; Veronika Grau
Journal:  Langenbecks Arch Surg       Date:  2008-02-19       Impact factor: 3.445

4.  Induction of MHC class II antigens on rat bronchial epithelial cells by interferon-gamma and its effect on antigen presentation.

Authors:  T Suda; A Sato; W Sugiura; K Chida
Journal:  Lung       Date:  1995       Impact factor: 2.584

5.  Studies on the surface phenotype and functions of dendritic cells in parenchymal lung tissue of the rat.

Authors:  P G Holt; J Oliver; C McMenamin; M A Schon-Hegrad
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

6.  Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.

Authors:  Amber M Johnson; Bonnie L Bullock; Alexander J Neuwelt; Joanna M Poczobutt; Rachael E Kaspar; Howard Y Li; Jeff W Kwak; Katharina Hopp; Mary C M Weiser-Evans; Lynn E Heasley; Erin L Schenk; Eric T Clambey; Raphael A Nemenoff
Journal:  J Immunol       Date:  2020-03-16       Impact factor: 5.422

7.  Fraction of MHCII and EpCAM expression characterizes distal lung epithelial cells for alveolar type 2 cell isolation.

Authors:  Koichi Hasegawa; Atsuyasu Sato; Kazuya Tanimura; Kiyoshi Uemasu; Yoko Hamakawa; Yoshinori Fuseya; Susumu Sato; Shigeo Muro; Toyohiro Hirai
Journal:  Respir Res       Date:  2017-08-07

8.  Piezo1 induced apoptosis of type II pneumocytes during ARDS.

Authors:  Guo-Peng Liang; Jing Xu; Li-Li Cao; Yi-Hua Zeng; Bai-Xu Chen; Jing Yang; Zhong-Wei Zhang; Yan Kang
Journal:  Respir Res       Date:  2019-06-11

9.  Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation.

Authors:  Sushila A Toulmin; Chaitali Bhadiadra; Andrew J Paris; Jeffrey H Lin; Jeremy Katzen; Maria C Basil; Edward E Morrisey; G Scott Worthen; Laurence C Eisenlohr
Journal:  Nat Commun       Date:  2021-06-28       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.